研究说明:在化中的相对生物可用性对于小
M Smiricky-Tjardes1, P Utterback2, J Blair2
1Independent Consultant, Blair, NE 68008, USA.
Poultry science
|December 30, 2023
概括
与硫酸相比,一种新的化来源 (SAMZn) 在小中显示出更高的生物可用性. 这一发现确定了其对动物营养和料配方的价值.
科学领域:
- 动物营养 动物营养
- 微量矿物质的生物可用性
- 禽畜科学 禽畜科学 禽畜科学
背景情况:
- 是一种重要的微量元素,对动物生长和健康至关重要.
- 不同的来源在生物可用性方面有所不同,这会影响动物的表现.
- 确定新来源的相对生物利用率 (RBV) 对料配方至关重要.
研究的目的:
- 为了评估一种新的化 (SAMZn) 对 performance 的影响.
- 为了确定相对生物利用价值 (RBV) 的SAMZn相比硫酸.
- 要将SAMZn与另一种氧化来源 (IBZn) 进行比较.
主要方法:
- 使用缺乏的饮食进行了一项小测试.
- 小补充了不同水平的硫酸 (ZnSO4),SAMZn或IBZn.
- 分析了性能指标,包括体重增加和含量.
主要成果:
- 补充剂增加体重,无论来源如何.
- SAMZn显示RBV较高 (115%) 与硫酸盐 (100%) 相比,基于.
- SAMZn的性能和阴含量与同等补充剂的IBZn相当.
结论:
- 与级硫酸相比,化来源 (SAMZn) 在小中表现出更高的生物利用性.
- SAMZn的生物可用性与另一种氧化来源 (IBZn) 的生物可用性相当.
- SAMZn是一种高度生物可利用的来源,适合用于家禽营养.
更多相关视频
相关概念视频
Bioavailability: Overview
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
Bioavailability: Overview
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
Bioavailability: Influencing Factors
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...


